{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T22:50:47Z","timestamp":1715986247510},"reference-count":25,"publisher":"Japanese Society of Internal Medicine","issue":"14","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2016]]},"DOI":"10.2169\/internalmedicine.55.6326","type":"journal-article","created":{"date-parts":[[2016,7,14]],"date-time":"2016-07-14T22:10:38Z","timestamp":1468534238000},"page":"1899-1905","source":"Crossref","is-referenced-by-count":7,"title":["The Successful Treatment of Calciphylaxis with Sodium Thiosulfate and Hyperbaric Oxygen in a Non-dialyzed Patient with Chronic Kidney Disease"],"prefix":"10.2169","volume":"55","author":[{"given":"Seishi","family":"Aihara","sequence":"first","affiliation":[{"name":"Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunsuke","family":"Yamada","sequence":"additional","affiliation":[{"name":"Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yushi","family":"Uchida","sequence":"additional","affiliation":[{"name":"Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hokuto","family":"Arase","sequence":"additional","affiliation":[{"name":"Department of Nephrology, St. Mary's Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Tsuchimoto","sequence":"additional","affiliation":[{"name":"Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiaki","family":"Nakano","sequence":"additional","affiliation":[{"name":"Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatomo","family":"Taniguchi","sequence":"additional","affiliation":[{"name":"Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harumichi","family":"Higashi","sequence":"additional","affiliation":[{"name":"Department of Nephrology, St. Mary's Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takanari","family":"Kitazono","sequence":"additional","affiliation":[{"name":"Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiko","family":"Tsuruya","sequence":"additional","affiliation":[{"name":"Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Japan"},{"name":"Department of Integrated Therapy for Chronic Kidney Disease, Graduate School of Medical Sciences, Kyushu University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Nigwekar SU, Kroshinsky D, Nazarian RM, et al. Calciphylaxis: risk factors, diagnosis, and treatment. Am J Kidney Dis 66: 133-146, 2015.","DOI":"10.1053\/j.ajkd.2015.01.034"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Rogers NM, Coates PT. Calcific uremic arteriolopathy: an update. Curr Opin Nephrol Hypertens 17: 629-634, 2008.","DOI":"10.1097\/MNH.0b013e32830f4566"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Hayashi M, Takamatsu I, Kanno Y, et al. A case-control study of calciphylaxis in Japanese end-stage renal disease patients. Nephrol Dial Transplant 27: 1580-1584, 2012.","DOI":"10.1093\/ndt\/gfr658"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Schafer C, Heiss A, Schwarz A, et al. The serum protein \u03b1<sub>2<\/sub>-Heremans-Schmid glycoprotein\/fetuin-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest 112: 357-366, 2003.","DOI":"10.1172\/JCI17202"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Jahnen-Dechent W, Heiss A, Sch\u00e4fer C, Ketteler M. Fetuin-A regulation of calcified matrix metabolism. Circ Res 108: 1494-1509, 2011.","DOI":"10.1161\/CIRCRESAHA.110.234260"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Price PA, Williamson MK, Nguyen TM, Than TN. Serum levels of the fetuin-mineral complex correlate with artery calcification in the rat. J Biol Chem 279: 1594-1600, 2004.","DOI":"10.1074\/jbc.M305199200"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. Ketteler M, Bongartz P, Westenfeld R, et al. Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study. Lancet 361: 827-833, 2003.","DOI":"10.1016\/S0140-6736(03)12710-9"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Smith ER, Ford ML, Tomlinson LA, Rajkumar C, McMahon LP, Holt SG. Phosphorylated fetuin-A-containing calciprotein particles are associated with aortic stiffness and a procalcific milieu in patients with pre-dialysis CKD. Nephrol Dial Transplant 27: 1957-1966, 2012.","DOI":"10.1093\/ndt\/gfr609"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Hamano T, Matsui I, Mikami S, et al. Fetuin-mineral complex reflects extraosseous calcification stress in CKD. J Am Soc Nephrol 21: 1998-2007, 2010.","DOI":"10.1681\/ASN.2009090944"},{"key":"10","first-page":"1","volume":"34","author":"M Kuro-o","year":"2014","unstructured":"10. Kuro-o M. Calciprotein particle (CPP): a true culprit of phosphorus woes? Nefrologia 34: 1-4, 2014.","journal-title":"Nefrologia","ISSN":"http:\/\/id.crossref.org\/issn\/0211-6995","issn-type":"print"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Yamada S, Tokumoto M, Tatsumoto N, et al. Phosphate overload directly induces systemic inflammation and malnutrition as well as vascular calcification in uremia. Am J Physiol Renal Physiol 306: 1418-1428, 2014.","DOI":"10.1152\/ajprenal.00633.2013"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Nadra I, Mason JC, Philippidis P, et al. Proinflammatory activation of macrophages by basic calcium phosphate crystals via protein kinase C and MAP kinase pathways: a vicious cycle of inflammation and arterial calcification? Circ Res 96: 1248-1256, 2005.","DOI":"10.1161\/01.RES.0000171451.88616.c2"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Dautova Y, Kozlova D, Skepper JN, Epple M, Bootman MD, Proudfoot D. Fetuin-A and albumin alter cytotoxic effects of calcium phosphate nanoparticles on human vascular smooth muscle cells. PLoS One 9: e97565, 2014.","DOI":"10.1371\/journal.pone.0097565"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Selk N, Rodby RA. Unexpectedly severe metabolic acidosis associated with sodium thiosulfate therapy in a patient with calcific uremic arteriolopathy. Semin Dial 24: 85-88, 2011.","DOI":"10.1111\/j.1525-139X.2011.00848.x"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Fukagawa M, Yumita S, Akizawa T, et al. Cinacalcet (KRN1493) effectively decreases the serum intact PTH level with favorable control of the serum phosphorus and calcium levels in Japanese dialysis patients. Nephrol Dial Transplant 23: 328-335, 2008.","DOI":"10.1093\/ndt\/gfm534"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Floege J, Kubo Y, Floege A, Chertow GM, Parfrey PS. The effect of cinacalcet on calcific uremic arteriolopathy events in patients receiving hemodialysis: the EVOLVE trial. Clin J Am Soc Nephrol 10: 800-807, 2015.","DOI":"10.2215\/CJN.10221014"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Ning MS, Dahir KM, Castellanos EH, McGirt LY. Sodium thiosulfate in the treatment of non-uremic calciphylaxis. J Dermatol 40: 649-652, 2013.","DOI":"10.1111\/1346-8138.12139"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Fischer DC, Schaible J, Wigger M, et al. Reduced serum fetuin-A in nephrotic children: a consequence of proteinuria? Am J Nephrol 34: 373-380, 2011.","DOI":"10.1159\/000331061"},{"key":"19","doi-asserted-by":"publisher","unstructured":"19. Tintut Y, Patel J, Parhami F, Demer LL. Tumor necrosis factor-\u03b1 promotes in vitro calcification of vascular cells via the cAMP pathway. Circulation 102: 2636-2642, 2000.","DOI":"10.1161\/01.CIR.102.21.2636"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Herrmann M, Sch\u00e4fer C, Heiss A, et al. Clearance of fetuin-A-containing calciprotein particles is mediated by scavenger receptor-A. Circ Res 111: 575-584, 2012.","DOI":"10.1161\/CIRCRESAHA.111.261479"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Smith ER, Cai MM, McMahon LP, et al. Serum fetuin-A concentration and fetuin-A-containing calciprotein particles in patients with chronic inflammatory disease and renal failure. Nephrology (Carlton) 18: 215-221, 2013.","DOI":"10.1111\/nep.12021"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Nigwekar SU, Brunelli SM, Meade D, Wang W, Hymes J, Lacson E Jr. Sodium thiosulfate therapy for calcific uremic arteriolopathy. Clin J Am Soc Nephrol 8: 1162-1170, 2013.","DOI":"10.2215\/CJN.09880912"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. An J, Devaney B, Ooi KY, Ford S, Frawley G, Menahem S. Hyperbaric oxygen in the treatment of calciphylaxis: a case series and literature review. Nephrology (Carlton) 20: 444-450, 2015.","DOI":"10.1111\/nep.12433"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Weenig RH, Sewell LD, Davis MD, McCarthy JT, Pittelkow MR. Calciphylaxis: natural history, risk factor analysis, and outcome. J Am Acad Dermatol 56: 569-579, 2007.","DOI":"10.1016\/j.jaad.2006.08.065"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Sato T, Ichioka S. How should we manage multiple skin ulcers associated with calciphylaxis? J Dermatol 39: 966-968, 2012.","DOI":"10.1111\/j.1346-8138.2012.01510.x"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/55\/14\/55_55.6326\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T18:26:46Z","timestamp":1498328806000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/55\/14\/55_55.6326\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":25,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.55.6326","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}